Potassium Chloride / Potassium Gluconate
Potassium is a critical intracellular electrolyte essential for life. It plays a vital role in maintaining cellular resting membrane potentials, particularly in excitable tissues like the heart, skeletal muscle, and smooth muscle. **Clinical Pearls:** * **Hypokalemia** (low potassium) is a common complication of chronic kidney disease (especially in cats), aggressive diuresis, diabetic ketoacidosis (DKA), and severe gastrointestinal losses. * **Potassium Gluconate** is typically preferred for oral supplementation as it is less irritating to the GI tract and provides a mild alkalinizing effect. * **Potassium Chloride (KCl)** is the standard for intravenous supplementation but must **always** be diluted prior to administration to prevent fatal arrhythmias. * Total body potassium depletion may be severe even if serum levels appear normal, especially in the presence of acid-base disturbances (acidosis shifts potassium extracellularly).
Mechanism: Potassium is the principal intracellular cation in the body. It works primarily via the **Na+/K+ ATPase pump** to maintain the electrochemical gradient across cell membranes. * Maintains cellular tonicity and resting membrane potential โ essential for nerve impulse transmission. * Regulates smooth, skeletal, and cardiac muscle contraction. * Acts as a crucial cofactor in carbohydrate utilization and protein synthesis. * Essential for the maintenance of normal renal function.
Dosing by species
- Treatment of chronic mild hypokalemia (3.0-3.5 mEq/L) ยท 0.5-1 mEq/kg mixed in food once or twice daily ยท PO ยท q12-24h
- Treatment of chronic mild hypokalemia (Tumil-K powder) ยท 1/4 teaspoonful (2 mEq) per 4.5 kg body weight in food twice daily; adjust as necessary ยท PO ยท q12h
- Moderate to severe (<3.0 mEq/L) or acute hypokalemia ยท Rate should not exceed 0.5 mEq/kg/hour. Under dire circumstances (serum K < 2.0 mEq/L), rate can be increased to 1.5 mEq/kg/hour along with close EKG monitoring. ยท IV ยท Continuous
- Subcutaneous fluid supplementation (<10 kg patients) ยท 150 mL SC every 12 hours of isotonic fluids containing 30-35 mEq/L KCl ยท SC ยท q12h
- Oral maintenance supplementation ยท 2-4 mEq/day ยท PO ยท Daily ยท Using potassium gluconate.
- Sliding scale IV supplementation based on Serum K+ ยท Serum K+ <2 mEq/L = 60 mEq/1000 mL IV fluid; Serum K+ 2-2.5 mEq/L = 40 mEq/1000 mL IV fluid; Serum K+ 2.5-3 mEq/L = 30 mEq/1000 mL IV fluid; Serum K+ 3-3.5 mEq/L = 20 mEq/1000 mL IV fluid. Infusion rates should generally not exceed 0.5 mEq/kg/hour. ยท IV ยท Continuous
- Hypokalemia in 'downer' cows ยท 80 grams sodium chloride and 20 grams potassium chloride in 10 liters of water via stomach tube. Provide a bucket containing similar solution for cow to drink and another containing fresh water. ยท PO ยท Once
- Hypokalemia maintenance/treatment ยท 50 grams PO daily; 1 mEq/kg/hour IV drip ยท PO/IV ยท Daily/Continuous
Routes of administration
Contraindications
- Hyperkalemia
- Renal failure or severe renal impairment
- Severe hemolytic reactions
- Untreated Addison's disease (hypoadrenocorticism)
- Acute dehydration
- GI motility impairment (for solid oral dosage forms)
Adverse effects
- Hyperkalemia (muscle weakness, cardiac conduction disturbances)
- Gastrointestinal distress (vomiting, diarrhea) with oral therapy
- Vein irritation and phlebitis with IV therapy
Drug interactions
- ACE Inhibitors (e.g., enalapril) ยท Potassium retention may occur; increased risk for hyperkalemia.
- Digoxin ยท In patients with severe or complete heart block receiving digitalis therapy, it is often recommended not to use potassium salts.
- NSAIDs ยท Oral potassium given with non-steroidal anti-inflammatory agents may increase the risk of gastrointestinal adverse effects.
- Potassium-Sparing Diuretics (e.g., spironolactone) ยท Potassium retention may occur; increased risk for hyperkalemia.
Monitoring
- Serum potassium levels
- Other electrolytes (sodium, chloride, magnesium, calcium)
- Acid/base status
- Blood glucose
- ECG (especially during IV administration)
- CBC
- Urinalysis and renal function parameters
Overdose
Fatal hyperkalemia may develop if potassium salts are administered too rapidly IV or if potassium renal excretory mechanisms are impaired. **Clinical Signs of Hyperkalemia:** * Muscular weakness * Gastrointestinal disturbances * Severe cardiac conduction disturbances (bradycardia, atrial standstill, ventricular fibrillation, asystole) **Treatment of Hyperkalemia:** * Immediate discontinuation of the potassium supplement. * Continuous ECG, acid/base, and electrolyte monitoring. * **Medical interventions:** Glucose/insulin infusions (drives K+ into cells), sodium bicarbonate (alkalinization drives K+ into cells), calcium therapy (cardioprotective, antagonizes K+ effects on the heart), and polystyrene sulfonate resin (binds K+ in the GI tract).
VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturerโs current label.